-+ 0.00%
-+ 0.00%
-+ 0.00%

CORRECTED-SEISMIC PHARMACEUTICALS ANNOUNCES ENROLLMENT OF FIRST PATIENT IN GLOBAL PHASE 3 TRIAL OF ISTAROXIME IN CARDIOGENIC SHOCK (NOT 'COMMENCES GLOBAL PHASE 3 TRIAL')(SEPT 9)

Reuters·09/10/2026 20:30:54

Please log in to view news